BCATc inhibitor 2 ameliorated mitochondrial dysfunction and apoptosis in oleic acid-induced non-alcoholic fatty liver disease model

• Hauptverfasser: Zhuo Lu (Verfasst von), Gui-Feng Sun (Verfasst von), Xiao-An Pan (Verfasst von), Xin-Hui Qu (Verfasst von), Ping Yang (Verfasst von), Zhi-Ping Chen (Verfasst von), Xiao-Jian Han (Verfasst von), Tao Wang (Verfasst von)
• Format: Buch
• Veröffentlicht: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Nonalcoholic fatty liver disease (NAFLD) is a prevalent hepatic disease in the world. Disorders of branched chain amino acid (BCAA) metabolism is involved in various diseases. In this study, we aim to explore the role of BCAA metabolism in the development of NAFLD and the protective effect of BCATc...